BridgeBio Pharma
BBIO
BBIO
179 hedge funds and large institutions have $1.1B invested in BridgeBio Pharma in 2022 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 55 increasing their positions, 71 reducing their positions, and 25 closing their positions.
Holders
179
Holders Change
-2
Holders Change %
-1.1%
% of All Funds
2.89%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
24
Increased
55
Reduced
71
Closed
25
Calls
$2.08M
Puts
$761K
Net Calls
+$1.32M
Net Calls Change
+$5K
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$21.9M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$67.4M |
| 3 |
3
Barclays
London,
United Kingdom
|
$9.16M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$80.7M |
| 5 |
5
BlackRock
New York
|
$74.4M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
EC
201
Elequin Capital
New York
| – | – | -549 | Closed |
|
|
CAL
202
Capital Advisors Ltd
Shaker Heights,
Ohio
| – | – | -18 | Closed |
|
|
C
203
Covestor
London,
United Kingdom
| $0 | 18 | -1 | -5% |
|
|
CM
204
Caption Management
Oklahoma City,
Oklahoma
| – | – | – | – |
|
205
Balyasny Asset Management
Chicago,
Illinois
| – | – | – | – |
|
|
CFGS
206
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
ACM
207
Advent Capital Management
New York
| – | – | – | – |
|
208
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|
209
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|
|
SFG
210
Steward Financial Group
Colleyville,
Texas
| $0 | 5 | +5 | New |
|